Orlando Sleep Medicine Center

eXciteOSA® is the world’s first daytime therapy that is FDA Authorized for reducing mild obstructive sleepapnea (OSA) and snoring. eXciteOSA® targets the root cause of mild OSA and snoring – the loss of muscle tone of thetongue – rather than simply relieving the symptoms

Clinically Proven

• 90% of patients reported a reduction in snoring time

• 89% of bed partners reported a reduction of their partners snoring

• 79% of sleep apnea patients achieved a reduction in sleep apnea measures

Daytime Use for Nighttime Results

eXciteOSA® is the only daytime solution clinically proven to help with mild OSA and snoring. The non-invasive deviceonly needs to be worn for 20 minutes a day, 1 time each day, for 6 weeks. Therapy is only required twice a weekthereafter.

Easy to use

The smartphone app seamlessly connects to your eXciteOSA® device, making it easy to complete therapy sessions andtrack progress.

 

REFERENCES

1. E. Wessoleck et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22(Suppl 2): 47–52

2. A. Samaet al. Daytime Intraoral Neurostimulation with Snoozeal® for treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes, 2018

3. eXciteOSA® White Paper (2020). Clinical study of 115 patients with snoring or mild OSA (Apnea- Hypopnea Index (AHI) <15 n=65) completedthe trial. Objective snoring and respiratory parameters were recorded with 2 consecutive WatchPAT® night sleep studies before and after theuse of the device. An intra- oral tongue stimulator device was used for 20 mins, once a day for 6-week period. (Internal publication by SMT foreducational purposes and submission.)

Better Sleep Begins Here

 

Call — 407 704 8537

11 + 3 =